Vemlidy (tenofovir alafenamide)

pCPA File Number: 21029

Negotiation Status:

Concluded without agreement

Indication(s):

Hepatitis B

Sponsor/Manufacturer:

Gilead Sciences Canada Inc.

CDA-AMC Project Number:

SR0537-000

pCPA Engagement Letter Issued:

2018-09-25

Negotiation Process Concluded:

2018-10-31